Navigation Links
Scientists Show Stem Cells Don't Cause Cancer
Date:2/14/2008

Solving this problem is an important step before moving on to potential therapies

THURSDAY, Feb. 14 (HealthDay News) -- A major concern with using stem cells to treat disease has been the possibility that the retrovirus used to implant the cells might cause cancer, but now a group of scientists appears to have solved that problem.

In November, two groups of researchers -- one in Japan and one in the United States -- showed that adult human and mouse skin cells could be reprogrammed into stem cells similar to embryonic stem cells, which can be made into any type of cell. These cells, called induced pluripotent stem cells (iPS), could be the key to using stem cells to cure a variety of diseases.

In this latest study, published in the Feb. 14 issue of Science, the Japanese researchers prove these stem cells are made from normal mature adult cells, and they show that these stem cells can be implanted using a retrovirus without fear of causing cancer.

"This is a real nice follow-up and confirmation of the previous papers that looked at inducing normal cells to become stem cells," said Dr. Hugh Taylor, an associate professor at Yale University School of Medicine.

"The question that still existed from the previous paper was whether these stem cells were some sort of adult stem cells," Taylor said. "This paper shows that these stem cells are fully differentiated adult cells, that they can be reprogrammed into stem cells," he added. "You can probably take almost any adult cell and turn it into a stem cell."

In addition, there has been a fear that using a retrovirus to implant stem cells results in an increased risk of cancer. This study showed that doesn't happen, Taylor said. "It proves, without a doubt, that these cells are safe for human use," he noted.

However, Taylor thinks the cells need to be studied over a longer period to ensure they don't have an elevated cancer risk.

'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Microbial cheaters help scientists ID social genes
2. Scientists solve structure of gene regulator that plays key role in cancer
3. VEGF Neutralization Can Damage Brain Vessels, Say Schepens Eye Research Institute Scientists
4. VEGF neutralization can damage brain vessels, say Schepens Eye Research Institute scientists
5. Precious Time - Scientists discover how long heart failure patients can expect to live
6. UCLA stem cell scientists reprogram human skin cells into embryonic stem cells
7. Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells
8. Scientists from Europe, Israel and the US develop robotic rats to aid in rescue missions
9. Childrens Hospital scientists identify possible target for prevention and treatment of pneumonia
10. NIAID scientists identify new cellular receptor for HIV
11. ECNP launches research grant for young scientists
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists Show Stem Cells Don't Cause Cancer
Scientists Show Stem Cells Don't Cause Cancer
(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4
...ey Spears has been warned to stop drinking. Accord...d that she might have done irreparable damage to ...lor John Sundahl had told her: "If you fall off th...you will live. If you don't want to get sober for ...
...hat humans distant ancestors won the battle agains... left the human species vulnerable to HIV today. ...esent century and one of the most researched one s...d about its origin. Many researchers believe that ...
...shop owner was sentenced to two years probation fo...rced the evacuation of a rooming house beside his ...nts of sexual assault and one count of sexual expl...victims testified that Claro caressed and groped t...
...ermany have died of the feared H5N1 strain of bird...of a total of 14 birds tested positive for the H5N...itute institute said. A health official, Katja Gue...t tests carried out by the same institute confirme...
Other Medicine News:Health News:Ancient Ancestors Might Have Had a Clue to HIV 2Health News:Two Year Probation for Cobra Owner Helder Claro 2Health News:Six Cases of H5N1 Bird Flu Confirmed in Germany 2
(Date:10/13/2008)...nd SPIRIT III Data Confirms Patients Treated, with... a Heart Attack or a Repeat Procedure Co... 13 /- Data from an indepen...T III randomized clinical,trials demonstrated that...t,System continues to deliver clinically significa...
(Date:10/13/2008)...nd to Have Higher Sensitivity and Specificity, th...d was the preferred test in all ph...t. 13 /- AT First Diagnostic LLC an,e...stic test kits, today,announced that a recent eval... of Research of the FirstVue(TM) HBSAG Test, was r...
(Date:10/13/2008)... /- Facet Solutions, Inc. today,annou...ients from its US,IDE Pilot Study. The results sho...I) scores, and an 80% reduction in Visual Analog S... President & CEO for Facet Solutions,added, "We a...us far not,only demonstrate significant pain relie...
(Date:10/12/2008)...TON, Oct. 12 /- Boston,Scie...esults from an analysis,of nearly 7,500 patients f... designed to confirm the performance of the TAXUS(...System in real-world practice. The,two-year pooled...linical,restenosis in patients with diabetes as ef...
Breaking Medicine Technology:Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 2Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 3Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 4Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 5Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 2Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 3Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5Cancer Drug Appears to Help With Aggressive MS 21744 1Cancer Drug Appears to Help With Aggressive MS 21744 2MEDRAD and PETNET Solutions Partner for Innovative FDG Delivery 21741 1MEDRAD and PETNET Solutions Partner for Innovative FDG Delivery 21741 2MEDRAD and PETNET Solutions Partner for Innovative FDG Delivery 21741 3Chindex International Inc Quantifies Fourth Quarter Charges 5970 1Chindex International Inc Quantifies Fourth Quarter Charges 5970 2Chindex International Inc Quantifies Fourth Quarter Charges 5970 3AAAS hosts June 20 conference on personalized medicine 21736 1AAAS hosts June 20 conference on personalized medicine 21736 2
...S WIRE)--Jul 9, 2007 - Neose Technologies,Inc. (N... at the,C.E. Unterberg, Towbin Emerging Growth Opp...l Hotel in New York City from July,10-12, 2007. Th....,(EDT) on Tuesday, July 10, 2007. The presentatio...a the following link:, http://www.wsw.com/webcast/...
...y 05, 2007 /PRNewswire/ -- Alfacell,Corporation to...ice,president, chief financial officer and corpora...any,s product development programs,at 8 a.m. EDT o...Towbin Emerging Growth Opportunities Conference in... be available live at,<a target="_blank" href=,"ht...
Other Medicine Technology:Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging,Growth Opportunities Conference 2
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
Sugar-Chex Linearity is a whole blood formulation designed to cover the linear reportable range of the most popular glucose meters. The product meets CAP recommendations of using a control matrix tha
Medicine Products: